XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Net sales $ 1,915 $ 1,809 $ 5,370 $ 5,306
Cost of products sold 1,115 1,160 3,324 3,429
Gross profit 800 649 2,046 1,877
Selling and administrative expenses 311 233 854 710
Advertising costs 206 153 523 502
Research and development costs 35 31 100 98
Goodwill, trademark and other asset impairments 445 0 445 0
Interest expense 24 21 69 69
Other (income) expense, net 24 11 54 20
Earnings (losses) before income taxes (245) 200 1 478
Income tax expense (benefit) (36) 48 21 111
Net earnings (losses) (209) 152 (20) 367
Less: Net earnings attributable to noncontrolling interests 2 2 7 6
Net earnings (losses) attributable to Clorox $ (211) $ 150 $ (27) $ 361
Net earnings (losses) per share attributable to Clorox        
Basic net earnings (losses) per share (in dollars per share) $ (1.71) $ 1.22 $ (0.22) $ 2.93
Diluted net earnings (losses) per share (in dollars per share) $ (1.71) $ 1.21 $ (0.22) $ 2.91
Weighted average shares outstanding (in thousands)        
Basic (in shares) 123,649 123,177 123,512 123,074
Diluted (in shares) 123,649 123,877 123,512 123,943
Comprehensive income (loss) $ (205) $ 207 $ (39) $ 394
Less: Total comprehensive income attributable to noncontrolling interests 2 2 7 6
Total comprehensive income (loss) attributable to Clorox $ (207) $ 205 $ (46) $ 388